<\/p>\n
LONDON–(BUSINESS THREAD<\/span><\/span>)–The Future Markets Research Tank (FMRT) is proud to publish market commentary on InnoCan Pharma, a leading pharma and CBD player poised to disrupt multiple markets. To read the full report click here<\/a>or follow the link: <\/a>\n<\/p>\n Key data:\n<\/p>\n InnoCan Pharma is also beginning to experience strong financial growth, demonstrating its commitment to its shareholders. The economic potential of InnoCan’s revolutionary technologies, drug discoveries, licensing agreements and drug pipelines suggest that investors could reap huge long-term rewards. Numerous studies indicate that CBD can be used more widely in the medical and healthcare sectors because it is effective in treating a variety of medical conditions. To address the perceived low bioavailability of CBD and significantly improve current delivery mechanisms, InnoCan is working on several cutting-edge drug delivery platforms. These platforms include LPT and exosomes drug delivery platforms, which promise to improve bioavailability performance. With the help of InnoCan’s cutting-edge technologies and recent pharmaceutical advances to target niche markets, the company is well positioned to gain significant first-mover advantages in key markets, increasing its potential economic With its innovative delivery solutions across different verticals, the company has the potential for long-term sustainable growth. With its emphasis on increased bioavailability, InnoCan is likely to lead the CBD-based veterinary healthcare market as well.<\/p>\n \nFuture Markets Research Tank staff commented: \nTo read the full report click here,<\/a> or follow the link: <\/a>\n<\/p>\n
\n
“It is well established that CBD has immense potential as a therapeutic ingredient, therefore, given its low bioavailability and rapid degradation in the liver, it should not yet be administered to humans as a drug. InnoCan Pharma continues to achieve monumental milestones in the development of CBD-based pharmaceutical products that have applications in a variety of growing industries. The combination of fiscal responsibility, world-class leadership and innovative technologies positions the company well for growth and industry leadership.”\n<\/p>\n